CDC Identifies Contamination in More Medical Products From New England Compounding Center

Share on Facebook
The CDC and the FDA have identified additional microbial contamination in medical products from the New England Compounding Center, which was linked to a multistate outbreak of fungal meningitis, according to an ASCA report.

The CDC has identified additional microbial contamination in unopened vials of betamethasone, cardioplegia and triamcinolone solutions that were distributed and recalled from NECC.

Clinicians should continue to report infections related to NECC products to FDA's MedWatch and state health departments.

Related Articles on ASC Medical Supplies:
Access MediQuip Names Patrick McCarthy Chief Network Development Officer
Volcano Corp. to Acquire Crux Biomedical
FDA Enters Partnership to Help Increase Access to New Medical Devices

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's ASC Review

Flexion Therapeutics prices underwritten public offering of 5.04M shares

Read Now